DK0706517T3 - Pyridazinonderivater med farmaceutisk virkning - Google Patents

Pyridazinonderivater med farmaceutisk virkning

Info

Publication number
DK0706517T3
DK0706517T3 DK94918564T DK94918564T DK0706517T3 DK 0706517 T3 DK0706517 T3 DK 0706517T3 DK 94918564 T DK94918564 T DK 94918564T DK 94918564 T DK94918564 T DK 94918564T DK 0706517 T3 DK0706517 T3 DK 0706517T3
Authority
DK
Denmark
Prior art keywords
group
atom
alkyl group
pct
hydrogen atom
Prior art date
Application number
DK94918564T
Other languages
English (en)
Inventor
Keizo Tanikawa
Akira Saito
Mitsuaki Hirotsuka
Ken-Ichi Shikada
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Application granted granted Critical
Publication of DK0706517T3 publication Critical patent/DK0706517T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22Nitrogen and oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK94918564T 1993-06-29 1994-06-24 Pyridazinonderivater med farmaceutisk virkning DK0706517T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP15919493 1993-06-29
JP11272194 1994-05-26
PCT/JP1994/001015 WO1995001343A1 (en) 1993-06-29 1994-06-24 Pyridazinone derivatives with pharmaceutical activity

Publications (1)

Publication Number Publication Date
DK0706517T3 true DK0706517T3 (da) 1999-06-28

Family

ID=26451823

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94918564T DK0706517T3 (da) 1993-06-29 1994-06-24 Pyridazinonderivater med farmaceutisk virkning

Country Status (22)

Country Link
US (2) US5728702A (da)
EP (1) EP0706517B1 (da)
KR (1) KR100255416B1 (da)
CN (1) CN1044906C (da)
AT (1) ATE172454T1 (da)
AU (1) AU676341B2 (da)
CA (1) CA2166326C (da)
CZ (1) CZ289231B6 (da)
DE (1) DE69414112T2 (da)
DK (1) DK0706517T3 (da)
ES (1) ES2124413T3 (da)
FI (1) FI113963B (da)
HU (1) HU221009B1 (da)
IL (1) IL110040A (da)
NO (1) NO306675B1 (da)
NZ (1) NZ267510A (da)
RO (1) RO114791B1 (da)
RU (1) RU2138486C1 (da)
SK (1) SK280786B6 (da)
TW (1) TW408114B (da)
UA (1) UA34481C2 (da)
WO (1) WO1995001343A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE192741T1 (de) * 1994-01-25 2000-05-15 Nissan Chemical Ind Ltd Pyridazinon-derivate
DE4430755A1 (de) * 1994-08-30 1996-03-07 Boehringer Mannheim Gmbh Neue Phosphanoxide, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US6207665B1 (en) 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
CA2326506A1 (en) * 1998-03-31 1999-10-07 Nissan Chemical Industries, Ltd. Pyridazinone hydrochloride compound and method for producing the same
CN1166653C (zh) * 1999-11-11 2004-09-15 日产化学工业株式会社 苄胺化合物的制造方法
WO2003035627A1 (en) 2001-10-22 2003-05-01 Pfizer Products Inc. Piperazine derivatives with ccr1 receptor antagonist activity
US20060080140A1 (en) * 2004-02-09 2006-04-13 Epic Systems Corporation System and method for providing a clinical summary of patient information in various health care settings
WO2010099388A1 (en) * 2009-02-27 2010-09-02 Indigo Pharmaceuticals Combinational use of a pde3 inhibitor and other agents
CN116768868B (zh) * 2023-08-15 2023-12-08 云南省药物研究所 一种哒嗪酮硫代衍生物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0186817B1 (en) * 1984-12-10 1989-08-02 Nissan Chemical Industries Ltd. 3(2h)pyridazinone, process for its preparation and anti-allergic agent containing it
JPH0641454B2 (ja) * 1985-02-27 1994-06-01 日産化学工業株式会社 ピリダジノン誘導体
US4892947A (en) * 1985-04-27 1990-01-09 Nissan Chemical Industries Ltd. 3(2H)Pyridazinone, process for its preparation and anti-allergic agent containing it
US4978665A (en) * 1987-01-20 1990-12-18 Nissan Chemical Industries Ltd. 3(2H)pyridazinone, and antagonistic agent against SRS-A containing it
JPH02256668A (ja) * 1988-12-20 1990-10-17 Nissan Chem Ind Ltd ピリダジノン誘導体
UA27031A1 (uk) * 1990-04-25 2000-02-28 Ніссан Кемікал Індастріз Лтд Похідhі 3(2h)піридазиhоhу або їх фармацевтичhо прийhятhі солі, що мають протитромботичhу, позитивhу іhотропhу, судиhорозширювальhу дію й аhтиалергічhу активhість та фармацевтичhа композиція hа їх осhові
ATE192741T1 (de) * 1994-01-25 2000-05-15 Nissan Chemical Ind Ltd Pyridazinon-derivate

Also Published As

Publication number Publication date
NO306675B1 (no) 1999-12-06
RU2138486C1 (ru) 1999-09-27
CZ329995A3 (en) 1996-04-17
US5728702A (en) 1998-03-17
FI113963B (fi) 2004-07-15
ATE172454T1 (de) 1998-11-15
KR960703401A (ko) 1996-08-17
DE69414112D1 (de) 1998-11-26
UA34481C2 (uk) 2001-03-15
NO955328L (no) 1996-02-28
DE69414112T2 (de) 1999-03-11
CA2166326C (en) 2005-02-01
ES2124413T3 (es) 1999-02-01
IL110040A0 (en) 1994-10-07
IL110040A (en) 2000-07-16
CA2166326A1 (en) 1995-01-12
KR100255416B1 (ko) 2000-05-01
FI956300A (fi) 1995-12-28
CN1126470A (zh) 1996-07-10
HU9503807D0 (en) 1996-02-28
WO1995001343A1 (en) 1995-01-12
US5929074A (en) 1999-07-27
HU221009B1 (hu) 2002-07-29
NZ267510A (en) 1996-10-28
EP0706517A1 (en) 1996-04-17
EP0706517B1 (en) 1998-10-21
SK162495A3 (en) 1996-11-06
NO955328D0 (no) 1995-12-28
CZ289231B6 (cs) 2001-12-12
AU6983394A (en) 1995-01-24
SK280786B6 (sk) 2000-07-11
RO114791B1 (ro) 1999-07-30
HUT73483A (en) 1996-08-28
TW408114B (en) 2000-10-11
FI956300A0 (fi) 1995-12-28
CN1044906C (zh) 1999-09-01
AU676341B2 (en) 1997-03-06

Similar Documents

Publication Publication Date Title
HUP0103884A2 (hu) Arilszulfonanilidkarbamid-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0400828A2 (hu) Kondenzált heterociklikus aminopirimidinek, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
HUP0402313A2 (hu) Szerotonin újrafelvételt gátló fenilpiperazin-származékok, az ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
DK0794949T3 (da) Hidtil ukendte 3,5-dioxo-(2H,4H)-1,2,4-triazinderivater, fremstilling heraf og deres anvendelse som lægemidler
DK0706517T3 (da) Pyridazinonderivater med farmaceutisk virkning
NO995638L (no) Heterobicykliske forbindelser til fremstilling av pyridonkarboksylsyrederivater
MXPA02012569A (es) Ftalidas substituidas novedosas, un procedimiento para su preparacion y las composiciones farmaceuticas que contienen a las mismas.
DE69719974T2 (de) Chinolinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
NO972938L (no) Farmasöytiske piperazinforbindelser
DK0832079T3 (da) Antiiskæmiske hydroxylaminderivater og farmaceutiske sammensætninger
BR9812928A (pt) Novos derivados de 3-oxo-(2h) -1,2,4-triazina, processo de preparação de compostos quìmicos, e, composição farmacêutica
FR2757161B1 (fr) Diphenylalkyl-tetrahydropyridines
DK0651747T3 (da) Carbostyrilderivater